Correspondence 0001193125-23-277896 from Phathom Pharmaceuticals, Inc. (PHAT) (CIK 0001783183) (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT) (CIK 0001783183)
Date: Nov. 15, 2023 · CIK: 0001783183 · Accession: 0001193125-23-277896
AI Filing Summary & Sentiment
File numbers found in text: 333-275431
Letter
Phathom Pharmaceuticals, Inc.
100 Campus Drive, Suite 102
Florham Park, New Jersey 07932
November 15, 2023
VIA EDGAR
Alan Campbell
Office of Life Sciences
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Phathom Pharmaceuticals, Inc.
Registration Statement on Form S-3
File No. 333-275431
To the addressee set forth above:
Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Phathom Pharmaceuticals, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on November 17, 2023, or as soon as practicable thereafter.
If you have any questions or require additional information, please contact Anthony Gostanian of Latham & Watkins LLP at (858) 523-3969. Thank you for your assistance and cooperation in this matter.
Sincerely,
PHATHOM PHARMACEUTICALS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Phathom Pharmaceuticals, Inc. 100 Campus Drive, Suite 102 Florham Park, New Jersey 07932 November 15, 2023 VIA EDGAR Alan Campbell Office of Life Sciences Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Phathom Pharmaceuticals, Inc. Registration Statement on Form S-3 File No. 333-275431 To the addressee set forth above: Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Phathom Pharmaceuticals, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on November 17, 2023, or as soon as practicable thereafter. If you have any questions or require additional information, please contact Anthony Gostanian of Latham & Watkins LLP at (858) 523-3969. Thank you for your assistance and cooperation in this matter. Sincerely, PHATHOM PHARMACEUTICALS, INC. By: /s/ Larry Miller Larry Miller General Counsel cc: Terrie Curran, Phathom Pharmaceuticals, Inc. Matthew T. Bush, Latham & Watkins LLP Anthony Gostanian, Latham & Watkins LLP